TY - JOUR
T1 - GESIDA/PETHEMA recommendations on the diagnosis and treatment of lymphomas in patients infected by the human immunodeficiency virus
AU - Miralles, Pilar
AU - Navarro, José Tomás
AU - Berenguer, Juan
AU - Gómez Codina, José
AU - Kwon, Mi
AU - Serrano, David
AU - Díez-Martín, José Luis
AU - Villà, Salvador
AU - Rubio, Rafael
AU - Menárguez, Javier
AU - Ribera Santasusana, José María
PY - 2018/7/13
Y1 - 2018/7/13
N2 - © 2017 Elsevier España, S.L.U. The incidence of non-Hodgkin's lymphoma and Hodgkin's lymphoma is higher in patients with HIV infection than in the general population. Following the introduction of combination antiretroviral therapy (cART), the prognostic significance of HIV-related variables has decreased, and lymphoma-related factors have become more pronounced. Currently, treatments for lymphomas in HIV-infected patients do not differ from those used in the general population. However, differentiating characteristics of seropositive patients, such as the need for cART and specific prophylaxis and treatment of certain opportunistic infections, should be considered. This document updates recommendations on the diagnosis and treatment of lymphomas in HIV infected patients published by GESIDA/PETHEMA in 2008.
AB - © 2017 Elsevier España, S.L.U. The incidence of non-Hodgkin's lymphoma and Hodgkin's lymphoma is higher in patients with HIV infection than in the general population. Following the introduction of combination antiretroviral therapy (cART), the prognostic significance of HIV-related variables has decreased, and lymphoma-related factors have become more pronounced. Currently, treatments for lymphomas in HIV-infected patients do not differ from those used in the general population. However, differentiating characteristics of seropositive patients, such as the need for cART and specific prophylaxis and treatment of certain opportunistic infections, should be considered. This document updates recommendations on the diagnosis and treatment of lymphomas in HIV infected patients published by GESIDA/PETHEMA in 2008.
KW - AIDS
KW - Antiretroviral therapy
KW - HIV
KW - Hodgkin's lymphoma
KW - Non-Hodgkin's lymphoma
U2 - 10.1016/j.medcli.2017.11.037
DO - 10.1016/j.medcli.2017.11.037
M3 - Article
VL - 151
SP - 39.e1-39.e17
IS - 1
ER -